stockrow
Friday 6 November 2026
Export TLSA’s income statement to Excel — free account
Tiziana Life Sciences Ltd
TLSA Healthcare Biotechnology
0.62
0.02
−3.13%
Follow TLSA
Alert me
Tiziana Life Sciences Ltd (TLSA) P/E ratio
Tiziana Life Sciences Ltd has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GNLX Genelux Corporation compare | n/m |
| NRXS Neuraxis, Inc. compare | n/m |
| RANI Rani Therapeutics Holdings, Inc. compare | n/m |
| CLLS Cellectis S.A. compare | n/m |
| TNXP Tonix Pharmaceuticals Holding Corp. compare | n/m |
| TNYA Tenaya Therapeutics, Inc. compare | n/m |
| ATRA Atara Biotherapeutics, Inc. compare | n/m |
| TLSA Tiziana Life Sciences Ltd | n/m |
| RLYB Rallybio Corporation compare | 3.3× |
| Biotechnology industry median | 10.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)